According to our (Global Info Research) latest study, the global Single-target MET TKIs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Single-target MET tyrosine kinase inhibitors (TKIs) are drugs specifically designed to block the activity of the MET receptor tyrosine kinase alone, focusing on disrupting the MET signaling pathway that promotes cancer cell growth, survival, and metastasis.
This report is a detailed and comprehensive analysis for global Single-target MET TKIs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Single-target MET TKIs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Single-target MET TKIs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Single-target MET TKIs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Single-target MET TKIs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Single-target MET TKIs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Single-target MET TKIs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Merck, WuXi STA, Shanghai Hutchison Pharmaceuticals, Haihe Biopharma, CSPC Pharmaceutical, Avistone Pharmaceuticals Biotechnology, Asymchem, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Single-target MET TKIs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Capmatinib
Tepotinib
Savolitinib
Glumetinib
Vebreltinib
Other
Market segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Major players covered
Novartis
Merck
WuXi STA
Shanghai Hutchison Pharmaceuticals
Haihe Biopharma
CSPC Pharmaceutical
Avistone Pharmaceuticals Biotechnology
Asymchem
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Single-target MET TKIs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Single-target MET TKIs, with price, sales quantity, revenue, and global market share of Single-target MET TKIs from 2021 to 2026.
Chapter 3, the Single-target MET TKIs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Single-target MET TKIs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Single-target MET TKIs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Single-target MET TKIs.
Chapter 14 and 15, to describe Single-target MET TKIs sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Single-target MET TKIs. Industry analysis & Market Report on Single-target MET TKIs is a syndicated market report, published as Global Single-target MET TKIs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Single-target MET TKIs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.